Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,332 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial.
Harskamp RE, Alexander JH, Schulte PJ, Brophy CM, Mack MJ, Peterson ED, Williams JB, Gibson CM, Califf RM, Kouchoukos NT, Harrington RA, Ferguson TB Jr, Lopes RD. Harskamp RE, et al. Among authors: califf rm. JAMA Surg. 2014 Aug;149(8):798-805. doi: 10.1001/jamasurg.2014.87. JAMA Surg. 2014. PMID: 25073921 Free PMC article. Clinical Trial.
The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics.
Alexander JH, Ferguson TB Jr, Joseph DM, Mack MJ, Wolf RK, Gibson CM, Gennevois D, Lorenz TJ, Harrington RA, Peterson ED, Lee KL, Califf RM, Kouchoukos NT; PREVENT IV Investigators. Alexander JH, et al. Among authors: califf rm. Am Heart J. 2005 Oct;150(4):643-9. doi: 10.1016/j.ahj.2005.05.021. Am Heart J. 2005. PMID: 16209958
Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.
Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB Jr, Lorenz TJ, Goyal A, Gibson M, Mack MJ, Gennevois D, Califf RM, Kouchoukos NT; PREVENT IV Investigators. Alexander JH, et al. Among authors: califf rm. JAMA. 2005 Nov 16;294(19):2446-54. doi: 10.1001/jama.294.19.2446. JAMA. 2005. PMID: 16287955 Clinical Trial.
Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, Wolf RK, Cohn LH, Kouchoukos NT, Harrington RA, Gennevois D, Gibson CM, Califf RM, Ferguson TB Jr, Peterson ED; PREVENT IV Investigators. Goyal A, et al. Among authors: califf rm. Ann Thorac Surg. 2007 Mar;83(3):993-1001. doi: 10.1016/j.athoracsur.2006.10.046. Ann Thorac Surg. 2007. PMID: 17307447 Clinical Trial.
Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV.
Magee MJ, Alexander JH, Hafley G, Ferguson TB Jr, Gibson CM, Harrington RA, Peterson ED, Califf RM, Kouchoukos NT, Herbert MA, Mack MJ; PREVENT IV Investigators. Magee MJ, et al. Among authors: califf rm. Ann Thorac Surg. 2008 Feb;85(2):494-9; discussion 499-500. doi: 10.1016/j.athoracsur.2007.10.008. Ann Thorac Surg. 2008. PMID: 18222251 Clinical Trial.
Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters.
Olenchock SA Jr, Karmpaliotis D, Gibson WJ, Murphy SA, Southard MC, Ciaglo L, Buros J, Mack MJ, Alexander JH, Harrington RA, Califf RM, Kouchoukos NT, Ferguson TB Jr, Gibson CM. Olenchock SA Jr, et al. Among authors: califf rm. Ann Thorac Surg. 2008 Feb;85(2):520-4. doi: 10.1016/j.athoracsur.2007.10.061. Ann Thorac Surg. 2008. PMID: 18222256 Clinical Trial.
Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV).
Yau JM, Alexander JH, Hafley G, Mahaffey KW, Mack MJ, Kouchoukos N, Goyal A, Peterson ED, Gibson CM, Califf RM, Harrington RA, Ferguson TB; PREVENT IV Investigators. Yau JM, et al. Among authors: califf rm. Am J Cardiol. 2008 Sep 1;102(5):546-51. doi: 10.1016/j.amjcard.2008.04.069. Epub 2008 Jul 2. Am J Cardiol. 2008. PMID: 18721510 Clinical Trial.
Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgery.
Mehta RH, Hafley GE, Gibson CM, Harrington RA, Peterson ED, Mack MJ, Kouchoukos NT, Califf RM, Ferguson TB Jr, Alexander JH; Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT)-IV Investigators. Mehta RH, et al. Among authors: califf rm. J Thorac Cardiovasc Surg. 2008 Nov;136(5):1149-55. doi: 10.1016/j.jtcvs.2008.02.085. Epub 2008 Aug 27. J Thorac Cardiovasc Surg. 2008. PMID: 19026795 Free article.
Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery.
Lopes RD, Hafley GE, Allen KB, Ferguson TB, Peterson ED, Harrington RA, Mehta RH, Gibson CM, Mack MJ, Kouchoukos NT, Califf RM, Alexander JH. Lopes RD, et al. Among authors: califf rm. N Engl J Med. 2009 Jul 16;361(3):235-44. doi: 10.1056/NEJMoa0900708. N Engl J Med. 2009. PMID: 19605828 Free article. Clinical Trial.
Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: Results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT-IV) Trial.
Al-Khatib SM, Hafley G, Harrington RA, Mack MJ, Ferguson TB, Peterson ED, Califf RM, Kouchoukos NT, Alexander JH. Al-Khatib SM, et al. Among authors: califf rm. Am Heart J. 2009 Nov;158(5):792-8. doi: 10.1016/j.ahj.2009.09.003. Am Heart J. 2009. PMID: 19853700 Clinical Trial.
1,332 results